ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
Bioorganic & Medicinal Chemistry
Volume 15, Issue 4, 15 February 2007, Pages 1606-1614
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (273 K)

 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.bmc.2006.12.030    How to Cite or Link Using DOI (Opens New Window)
Copyright © 2006 Elsevier Ltd All rights reserved.

Lactotriaose-containing carbosilane dendrimers: Syntheses and lectin-binding activities

Akihiro Yamadaa, Ken Hatanoa, Tetsuo Koyamaa, Koji Matsuokaa, Naonori Takahashib, c, Kazuya I.P.J. Hidarib, c, Takashi Suzukib, c, Yasuo Suzukic, d and Daiyo Terunumaa, Corresponding Author Contact Information, E-mail The Corresponding Author

aArea for Molecular Function, Division of Material Science, Graduate School of Science and Engineering, Saitama University, 255 Shimo-ohkubo, Sakura-ku, Saitama 338-8570, Japan bDepartment of Biochemistry, University of Shizuoka, School of Pharmaceutical Sciences 52-1, Yada, Shizuoka-shi, Shizuoka 422-8526, Japan cCore Research for Evolutional Science and Technology (CREST), Japan Science and Technology Corporation, and COE Program in the 21st Century, Japan dDepartment of Biomedical Sciences, College of Life and Health Sciences, Chubu University, 1200 Matsumoto-cho, Kasugai-shi, Aichi 487-8501, Japan

Received 4 November 2006; 
revised 13 December 2006; 
accepted 14 December 2006. 
Available online 20 December 2006.

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Abstract

Carbosilane dendrimers periphery-functionalized with lactotriaose (GlcNAcβ1–3Galβ1–4Glc) with valencies of three, four, six, and twelve were prepared for use in a lectin-binding assay. A lactotriaose derivative was prepared from d-glucosamine and d-lactose derivatives. The N-Troc-protected glucosamine glycosyl donor and 3′-O-unprotected lactose glycosyl acceptor were condensed in the presence of silver trifluoromethanesulfonate and methylsulfenyl bromide to provide corresponding trisaccharide with new β-1-3 linkages in 92% yield. The protection group of the trisaccharide was transformed into an acetyl group. The 4-pentenyl glycoside was prepared from the acetate via glycosyl bromide. The alkene was converted into acetyl sulfide by addition of thioacetic acid under radical conditions. The lactotriaose unit was linked with carbosilane dendrimers to afford acetyl-protected glycodendrimers. De-O-acetylation of the dendrimers was carried out in the presence of sodium methoxide and then aq NaOH to give the desired lactotriaose clusters using a carbosilane dendrimer backbone. Their biological activities toward WGA were evaluated by fluorescence methods. The binding constants of free lactotriaose and trivalent, tetravalent, hexavalent, and dodecavalent glycodendrimers to WGA were determined to be 1.1 × 103, 4.4 × 104, 5.1 × 104, 2.8 × 106, and 1.3 × 106 M−1, respectively. The hexavalent glycodendrimer showed a 2500-fold larger binding effect than that of free lactotriaose.

Graphical abstract


Keywords: WGA; Glycocluster; Carbosilane dendrimer; Lactotriaose

Article Outline

1. Introduction
2. Results and discussion
2.1. Syntheses of glycodendrimers
2.2. Interaction of glycodendrimers with WGA
3. Conclusion
4. Experimental
4.1. General methods
4.1.1. Benzyl O-[3,4,6,-tri-O-acetyl-2-deoxy-2-(2,2,2,-trichloroethoxycarbonylamino)- β-d-glucopyranosyl]-(1 → 3)-O-(2,6-di-O-benzyl-4-O-acetyl-β-d-galactopyranosyl)-(1 → 4)-2,3,6-tri-O-benzyl-β-d-glucopyranoside (4)
4.1.1.1. Prepared from 1 and 2
4.1.1.2. Prepared from 1 and 3
4.1.2. Benzyl O-(2-acetoamido-3,4,6,-tri-O-acetyl-2-deoxy-β-d-glucopyranosyl)-(1 → 3)-O-(2,6-di-O-benzyl-4-O-acetyl-β-d-galactopyranosyl)-(1 → 4)-2,3,6-tri-O-benzyl-β-d-glucopyranoside (5)
4.1.3. O-(2-Acetoamido-3,4,6,-tri-O-acetyl-2-deoxy-β-d-glucopyranosyl)-(1 → 3)-O-(2,4,6-tri-O-acetyl-β-d-galactopyranosyl)-(1 → 4)-2,3,6-tri-O-acetyl-β-d-glucopyranosyl acetate (6)
4.1.4. O-(2-Acetamido-2-deoxy-β-d-glucopyranosyl)-(1 → 3)-O-(β-d-galactopyranosyl)-(1 → 4)-d-glucopyranose (7)
4.1.5. 4-Pentenyl (2-acetoamido-3,4,6,-tri-O-acetyl-2-deoxy-β-d-glucopyranosyl)-(1 → 3)-O-(2,4,6-tri-O-acetyl-β-d-galactopyranosyl)-(1 → 4)-2,3,6-tri-O-acetyl-β-d-glucopyranoside (8)
4.1.6. 5-Acetylthiopentyl (2-acetoamido-3,4,6,-tri-O-acetyl-2-deoxy-β-d-glucopyranosyl)-(1 → 3)-O-(2,4,6-tri-O-acetyl-β-d-galactopyranosyl)-(1 → 4)-2,3,6-tri-O-acetyl-β-d-glucopyranoside (9)
4.1.7. Acetylated trivalent glycodendrimer (14)
4.1.8. Acetylated tetravalent glycodendrimer (15)
4.1.9. Acetylated hexavalent glycodendrimer (16)
4.1.10. Acetylated dodecavalent glycodendrimer (17)
4.1.11. Trivalent glycodendrimer (18)
4.1.12. Tetravalent glycodendrimer (19)
4.1.13. Hexavalent glycodendrimer (20)
4.1.14. Dodecavalent glycodendrimer (21)
4.2. Fluorescence measurements
Acknowledgements
References




Bioorganic & Medicinal Chemistry
Volume 15, Issue 4, 15 February 2007, Pages 1606-1614
 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.